Transense Technologies (LON:TRT) Posts Earnings Results

Transense Technologies (LON:TRTGet Free Report) announced its quarterly earnings results on Tuesday. The company reported GBX 3.61 ($0.05) earnings per share for the quarter, Digital Look Earnings reports. Transense Technologies had a net margin of 37.44% and a return on equity of 30.05%.

Transense Technologies Price Performance

Shares of LON TRT opened at GBX 135.90 ($1.71) on Tuesday. Transense Technologies has a fifty-two week low of GBX 90 ($1.14) and a fifty-two week high of GBX 194.90 ($2.46). The stock has a market cap of £20.23 million, a price-to-earnings ratio of 13.09 and a beta of 0.38. The company has a debt-to-equity ratio of 7.26, a quick ratio of 2.95 and a current ratio of 5.17. The firm’s 50-day simple moving average is GBX 163.87 and its 200 day simple moving average is GBX 163.31.

Insider Activity at Transense Technologies

In other news, insider Ryan Maughan bought 3,025 shares of the company’s stock in a transaction on Wednesday, January 8th. The shares were purchased at an average price of GBX 165 ($2.08) per share, with a total value of £4,991.25 ($6,297.31). 14.82% of the stock is owned by insiders.

About Transense Technologies

(Get Free Report)

Transense is a developer of specialist wireless sensor systems used to enable real-time data gathering and monitoring. Products include the patent protected Surface Acoustic Wave (SAW) sensor technology, used to improve equipment power, performance, reliability and efficiency; iTrack, Transense’s Tyre Pressure Monitoring System, recently licensed to Bridgestone Corporation, the world’s largest tyre producer, under a ten-year deal; and a range of intelligent tyre monitoring equipment under the Translogik brand.

Featured Stories

Receive News & Ratings for Transense Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transense Technologies and related companies with MarketBeat.com's FREE daily email newsletter.